Announce Date | 02/13/2025 |
EPS Normalized Actual | $-2.82 (Miss by $-1.02) |
EPS GAAP Actual | $-2.82 (Miss by $-1.02) |
Revenue Actual | $7.3513B |
Revenue Surprise | Beat by $7351.3M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.95122 |
EPS GAAP Estimate | $1.95122 |
Revenue Estimate | $8.891939898B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.3 | 4.55 | 2.65557 | 4.02593 | 1 |
Dec 2028 | -4.45 | -3.37 | -6.18272 | -1.28916 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -2.54 | -2.54 | 7.3513B | -24.31% | 7351.3M |
FQ3 2024 (Sep 2024) | -2.443 | -2.443 | 8.3823B | -28.05% | 8382.3M |
FQ2 2024 (Jun 2024) | -0.56 | -0.56 | 8.7361B | -4.82% | 8736.1M |
FQ1 2024 (Mar 2024) | 0.89 | 0.89 | 8.6456B | -7.51% | 8645.6M |
FQ4 2023 (Dec 2023) | -0.4 | -0.4 | 9.1387B | -18.69% | 9138.7M |
FQ3 2023 (Sep 2023) | 6.35 | 6.35 | 10.7335B | -18.92% | 10733.5M |
FQ2 2023 (Jun 2023) | 8.14 | 8.14 | 9.1576B | 99.85% | 9157.6M |
FQ1 2023 (Mar 2023) | 2.97 | 2.97 | 9.295B | 100% | 9295M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.95122
Consensus Revenue Estimates
8.891939898B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.3536 | -- | 1.88227 | 2.8614 | 4 |
FQ2 2027 (Jun 2027) | 2.8077 | -- | 2.24543 | 3.41347 | 4 |
FQ1 2027 (Mar 2027) | -0.8383 | -- | -1.01917 | -0.67042 | 4 |
FQ4 2026 (Oct 2026) | 1.36136 | -- | 0.42311 | 1.75695 | 4 |
FQ3 2026 (Jul 2026) | 1.44707 | -- | 0.44974 | 1.86756 | 4 |
FQ2 2026 (Jun 2026) | 1.08475 | -- | 0.13384 | 1.52256 | 4 |
FQ1 2026 (Mar 2026) | 1.06425 | -- | 0.13131 | 1.49379 | 4 |
FQ4 2025 (Oct 2025) | 2.3078 | 210.06 | 0.71725 | 2.97841 | 5 |
FQ3 2025 (Jul 2025) | 2.27239 | 207.51 | 0.70625 | 2.93271 | 5 |
FQ2 2025 (Jun 2025) | 1.95122 | 128.7 | 0.24074 | 2.73875 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 15.16B | -- | 12.82B | 17.67B | 3 |
FQ2 2027 (Jun 2027) | 14.19B | -- | 12B | 16.55B | 3 |
FQ1 2027 (Mar 2027) | 13.29B | -- | 11.24B | 15.49B | 3 |
FQ4 2026 (Oct 2026) | 9.25B | -- | 4.35B | 11.32B | 4 |
FQ3 2026 (Jul 2026) | 9.15B | -- | 4.3B | 11.2B | 5 |
FQ2 2026 (Jun 2026) | 9.15B | -- | 2.98B | 11.99B | 5 |
FQ1 2026 (Mar 2026) | 9.05B | -- | 2.95B | 11.86B | 6 |
FQ4 2025 (Oct 2025) | 8.7B | 15.49 | 4.09B | 10.64B | 2 |
FQ3 2025 (Jul 2025) | 8.62B | 2.76 | 4.05B | 10.55B | 2 |
FQ2 2025 (Jun 2025) | 8.89B | 1.75 | 2.9B | 11.65B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -2.54 | -2.54 | 100% | |
FQ3 2024 (Sep 2024) | -2.443 | -2.443 | 100% | |
FQ2 2024 (Jun 2024) | -0.56 | -0.56 | 100% | |
FQ1 2024 (Mar 2024) | 0.89 | 0.89 | 100% | |
FQ4 2023 (Dec 2023) | -0.4 | -0.4 | 100% | |
FQ3 2023 (Sep 2023) | 6.35 | 6.35 | 100% | |
FQ2 2023 (Jun 2023) | 8.14 | 8.14 | 100% | |
FQ1 2023 (Mar 2023) | 2.97 | 2.97 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $7.35B | $7351.3M | 100% |
FQ3 2024 (Sep 2024) | $0B | $8.38B | $8382.3M | 100% |
FQ2 2024 (Jun 2024) | $0B | $8.74B | $8736.1M | 100% |
FQ1 2024 (Mar 2024) | $0B | $8.65B | $8645.6M | 100% |
FQ4 2023 (Dec 2023) | $0B | $9.14B | $9138.7M | 100% |
FQ3 2023 (Sep 2023) | $0B | $10.73B | $10733.5M | 100% |
FQ2 2023 (Jun 2023) | $0B | $9.16B | $9157.6M | 100% |
FQ1 2023 (Mar 2023) | $0B | $9.3B | $9295M | 100% |